NEKTAR THERAPEUTICS NEKTAR THER (0UNL.L) Financials

0UNL.L Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 442.2 million 282.9 million
2023-06-30 494.3 million 297.3 million
2023-03-31 561.7 million 320.9 million
2022-12-31 710.6 million 344.0 million

0UNL.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -42.2 million 8.1 million
2023-06-30 -51.7 million 8.0 million
2023-03-31 -52.3 million 10.0 million
2022-12-31 -58.2 million 12.7 million

0UNL.L Net Income

No data available :(

0UNL.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 372.7 million - -
2023-06-30 409.4 million - -
2023-03-31 456.8 million - -
2022-12-31 505.0 million - -

0UNL.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 190.4 million
2023-06-30 189.7 million
2023-03-31 188.9 million
2022-12-31 188.2 million

0UNL.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 33000 24.1 million 21.1 million -
2023-06-30 162000 29.7 million 17.9 million -
2023-03-31 433000 30.5 million 21.1 million -
2022-12-31 512000 34.7 million 21.9 million -

0UNL.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 24.1 million 12.4 million
2023-06-30 20.5 million 7.0 million
2023-03-31 21.6 million 7.1 million
2022-12-31 22.0 million 6.2 million

0UNL.L

Price: $1.74

52 week price:
0.44
1.81

Earnings Per Share: -2.66 USD

P/E Ratio: -0.27

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Market Capitalization: 3.1 million

Links: